May 28, 1999
Emory and Pharmaceutical Company Settle Patent Dispute Over a Promising Drug
Emory University and the Glaxo Wellcome pharmaceutical company have settled a dispute over rights to patents and data on a drug that shows promise in treating H.I.V. and hepatitis B.
University officials would not disclose the exact terms of the settlement. But they said the agreement would insure that a young biotechnology company with ties to Emory, Triangle Pharmaceuticals, had all the intellectual-property
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
